Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
주식 순위 #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
주가
$419.17
시가총액
$333.66B
변동 (1일)
0.50%
변동 (1년)
14.13%
국가
CH
거래 Roche Holding AG (ROG)

카테고리

Roche Holding AG (ROG)의 매출
Dec 2025 기준 매출 TTM: $77.52B
Roche Holding AG의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $77.52B입니다. 2024년에 회사는 $69.07B의 수익을 올렸으며 이는 2023년의 $71.87B 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Roche Holding AG의 수익 기록 (2000 ~ 2026)
매년 말 매출
연도 매출 변화
2026 (TTM) $77.52B 0.00%
2025 $77.52B 12.23%
2024 $69.07B -3.89%
2023 $71.87B 0.96%
2022 $71.19B 3.34%
2021 $68.88B 6.09%
2020 $64.93B -1.48%
2019 $65.90B 8.96%
2018 $60.48B 5.74%
2017 $57.20B 10.60%
2016 $51.72B 2.56%
2015 $50.42B 0.45%
2014 $50.20B -7.86%
2013 $54.48B 9.59%
2012 $49.71B 9.80%
2011 $45.28B -10.87%
2010 $50.80B 7.01%
2009 $47.47B 11.15%
2008 $42.71B 4.63%
2007 $40.82B 18.37%
2006 $34.48B 27.80%
2005 $26.98B -1.91%
2004 $27.51B 8.99%
2003 $25.24B 17.44%
2002 $21.49B 22.59%
2001 $17.53B -0.62%
2000 $17.64B 0.00%
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가